文献速递瓣膜外科

Mini-Stern试验:比较微型胸骨切开术与全胸骨正中切开术用于主动脉瓣置换术的随机试验

Mini-Stern Trial: A randomized trial comparing mini-sternotomy to full median sternotomy for aortic valve replacement.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-06-04

该随机对照试验在2家英国国家医疗服务体系医院纳入222例首次孤立主动脉瓣置换术患者,比较微型胸骨切开术(MS,n=118)与全胸骨正中切开术(FS,n=104)。MS组住院时间及达到出院适合状态的时间均长于FS组,调整后风险比未达统计学显著,且MS不具成本效益。

要点

  • MS组住院时间均值9.5天 vs FS组8.6天,达到出院适合状态时间均值8.5天 vs 7.5天。
  • 调整瓣膜类型、性别和外科医生后,MS对住院时间(HR 0.874,95%CI 0.668-1.143,P=0.3246)及出院适合时间(HR 0.907,95%CI 0.688-1.197,P=0.4914)无统计学显著影响。
  • 平均随访760天(MS组745天,FS组777天),MS组死亡12例(10%)vs FS组7例(7%),HR 1.871(95%CI 0.723-4.844,P=0.1966)。

核心结论

  • 与FS相比,MS未带来更短住院时间、更快恢复或生存改善,且不具成本效益;MS用于主动脉瓣置换术不优于FS。

研究设计与样本

  • 实用性、开放标签、平行随机对照试验,在2家英国国家医疗服务体系医院比较MS与FS用于首次孤立主动脉瓣置换术,按意向治疗人群分析,共招募并随机222例患者(MS组n=118,FS组n=104)。

主要发现

  • MS组住院时间均值9.5天 vs FS组8.6天;MS组达到出院适合状态时间均值8.5天 vs FS组7.5天。
  • 调整瓣膜类型、性别和外科医生后,MS相对FS对住院时间的HR为0.874(95%CI 0.668-1.143,P=0.3246),对达到出院适合状态的HR为0.907(95%CI 0.688-1.197,P=0.4914),均未达统计学显著。
  • 平均随访760天(MS组745天,FS组777天),MS组死亡12例(10%)vs FS组7例(7%),HR 1.871(95%CI 0.723-4.844,P=0.1966)。
  • 主动脉瓣置换术后前12个月,MS平均额外成本为1714英镑。

临床怎么用

  • 原文结论为MS用于主动脉瓣置换术不优于FS,未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aortic valve replacement (AVR) can be performed either through full median sternotomy (FS) or upper mini-sternotomy (MS). The Mini-Stern trial aimed to establish whether MS leads to quicker postoperative recovery and shorter hospital stay after first-time isolated AVR. METHODS: This pragmatic, open-label, parallel randomized controlled trial (RCT) compared MS with FS for first-time isolated AVR in 2 United Kingdom National Health Service hospitals. Primary endpoints were duration of postoperative hospital stay and the time to fitness for discharge from hospital after AVR, analyzed in the intent-to-treat population. RESULTS: In this RCT, 222 patients were recruited and randomized (n = 118 in the MS group; n = 104 in the FS group). Compared with the FS group, the MS group had a longer hospital length of stay (mean, 9.5 days vs 8.6 days) and took longer to achieve fitness for discharge home (mean, 8.5 days vs 7.5 days). Adjusting for valve type, sex, and surgeon, hazard ratios (HRs) from Cox models did not show a statistically significant effect of MS (relative to FS) on either hospital stay (HR, 0.874; 95% confidence interval [CI], 0.668-1.143; P = .3246) or time to fitness for discharge (HR, 0.907; 95% CI, 0.688-1.197; P value = .4914). During a mean follow-up of 760 days (745 days for the MS group and 777 days for the FS group), 12 patients (10%) in the MS group and 7 patients (7%) in the FS group died (HR, 1.871; 95% CI, 0.723-4.844; P = .1966). Average extra cost for MS was £1714 during the first 12 months after AVR. CONCLUSIONS: Compared with FS for AVR, MS did not result in shorter hospital stay, faster recovery, or improved survival and was not cost-effective. The MS approach is not superior to FS for performing AVR.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nair SK, Sudarshan CD, Thorpe BS, et al. Mini-Stern Trial: A randomized trial comparing mini-sternotomy to full median sternotomy for aortic valve replacement. J Thorac Cardiovasc Surg. 2018. PMID: 30075959. doi:10.1016/j.jtcvs.2018.05.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。